Solid lipid nanoparticles of irbesartan: Preparation, characterization, optimization and pharmacokinetic studies

Deepthi Soma, Zenab Attari, Meka Sreenivasa Reddy, Atmakuri Damodaram, Kunnatur Balasundara Gupta Koteshwara

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

Irbesartan is an antihypertensive with limited bioavailability and solid lipid nanoparticles (SLN) is one of the approaches to improve bioavailability. Solid lipid nanoparticles were prepared using glyceryl monostearate by solvent emulsification method followed by probe sonication. Irbesartan loaded SLNs were characterized and optimized by parameters like particle size, zeta potential, surface morphology entrapment efficiency and in vitro release. The optimized formulation was then further evaluated for the pharmacokinetic studies in Wistar rats. Irbesartan-loaded SLN of particle size 523.7 nm and 73.8% entrapment efficiency showed good bioavailability in Wistar rats and also showed optimum stability in the studies. The SLN prepared using glyceryl monostearate by solvent emulsification method leads to improve bioavailability of the drug.

Original languageEnglish
Article numbere15012
JournalBrazilian Journal of Pharmaceutical Sciences
Volume53
Issue number1
DOIs
Publication statusPublished - 2017

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Solid lipid nanoparticles of irbesartan: Preparation, characterization, optimization and pharmacokinetic studies'. Together they form a unique fingerprint.

Cite this